Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOSFOLD: Fosfomycin trometamol vs other antibiotics for acute E. coli pyelonephritis in elderly women
2025-521663-13-00Phase 3Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fosfomycin in acute pyelonephritis, urinary tract infection (UTI), sponsored by Assistance publique - Hôpitaux de Paris. Planned start Aug 2026; status: authorised.
02
Drugs
fosfomycin
03
Conditions
acute pyelonephritisurinary tract infection (UTI)
Beyond the preview
Go deeper on 2025-521663-13-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521663-13-00.